Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

POLARITYTE, INC.

(PTE)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-03 pm EST
0.7855 USD   -5.36%
01/26Polarityte, Inc. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
01/26Polarityte, Inc. Appoints Jeff Dyer as A Member of the Board of Directors
CI
01/13Polarityte, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

POLARITYTE, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

08/16/2021 | 05:03pm EST

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or

          Standard; Transfer of Listing.



On August 13, 2021, PolarityTE, Inc. (the "Company") received a deficiency letter from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market ("Nasdaq") notifying the Company that, for the preceding 30 consecutive business days, the bid price for the Company's common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the "Compliance Period Rule"), the Company has been provided an initial period of 180 calendar days to regain compliance with the Minimum Bid Price Requirement, which ends February 9, 2022 (the "Compliance Date"). If, at any time before the Compliance Date, the bid price for the Company's common stock closes at $1.00 or more for a minimum of 10 consecutive business days as required under the Compliance Period Rule, the Staff will provide written notification to the Company that it complies with the Bid Price Rule, unless the Staff exercises its discretion to extend this 10-day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H).

The Notice also provides that, if the Company does not regain compliance with the Minimum Bid Price Requirement by February 9, 2022, it may be eligible for additional time to regain compliance. To qualify for additional time, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and provide written notice of its intention to cure the minimum bid price deficiency during the second compliance period, by effecting a reverse split, if necessary. If the Company meets these requirements, it will be granted an additional compliance period of 180 calendar days to regain compliance with the Minimum Bid Price Requirement. If the Nasdaq staff determines that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible for such additional compliance period, Nasdaq will provide notice that the Company's Common Stock will be subject to delisting.

© Edgar Online, source Glimpses

All news about POLARITYTE, INC.
01/26Polarityte, Inc. : Change in Directors or Principal Officers, Financial Statements and Exh..
AQ
01/26Polarityte, Inc. Appoints Jeff Dyer as A Member of the Board of Directors
CI
01/13Polarityte, Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
01/13PolarityTE, Inc. Announces Resignation of Chris Nolet as Director
CI
2022Northland Securities Adjusts Price Target on PolarityTE to $1 From $1.25, Maintains Out..
MT
2022Sector Update: Health Care Edging Higher at Tuesday Close
MT
2022Sector Update: Health Care Stocks Still Struggling for Direction
MT
2022PolarityTE Says It Signed Tentative Agreement to Be Acquired
MT
2022Polarityte, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2022PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
PR
More news
Analyst Recommendations on POLARITYTE, INC.
More recommendations
Financials (USD)
Sales 2022 0,81 M - -
Net income 2022 -19,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,31x
Yield 2022 -
Capitalization 5,63 M 5,63 M -
Capi. / Sales 2022 6,92x
Capi. / Sales 2023 -
Nbr of Employees 64
Free-Float 83,3%
Chart POLARITYTE, INC.
Duration : Period :
PolarityTE, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends POLARITYTE, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,79 $
Average target price 1,00 $
Spread / Average Target 27,3%
EPS Revisions
Managers and Directors
Richard Hague President & Chief Executive Officer
Jacob Patterson Chief Financial Officer
Peter Anthony Cohen Chairman
Stephen Milner Chief Clinical Officer
Nikolai Sopko CSO, VP-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
POLARITYTE, INC.26.70%6
MODERNA, INC.-1.82%66 559
LONZA GROUP AG21.92%44 368
IQVIA HOLDINGS INC.15.76%44 054
ALNYLAM PHARMACEUTICALS, INC.-3.32%28 711
SEAGEN INC.7.38%25 622